Viewing Study NCT01332994


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2025-12-26 @ 2:44 AM
Study NCT ID: NCT01332994
Status: COMPLETED
Last Update Posted: 2015-09-07
First Post: 2011-03-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid Arthritis
Sponsor: Hoffmann-La Roche
Organization: